Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Assi

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|October 20, 2010
Syntaxin 4 is required for acid sphingomyelinase activity and apoptotic functionCristiana Perrotta, Laura Bizzozero, Denise Cazzato, et al.
American Journal of Nephrology|December 5, 2012
Possible pathogenetic relationship between Fabry disease and renal cell carcinomaFabio Pagni, Federico Pieruzzi, Stefano Zannella, et al.
Mediators of Inflammation|June 24, 2015
Modulation of Acid Sphingomyelinase in Melanoma Reprogrammes the Tumour Immune MicroenvironmentEmma Assi, Davide Cervia, Laura Bizzozero, et al.
Frontiers in Immunology|July 26, 2021
Hematopoietic Stem Cells in Type 1 DiabetesIda Pastore, Emma Assi, Moufida Ben Nasr, et al.
Oncotarget|April 24, 2016
Essential role for acid sphingomyelinase-inhibited autophagy in melanoma response to cisplatinDavide Cervia, Emma Assi, Clara De Palma, et al.
Oncotarget|May 21, 2016
Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse modelsMimma Bianco, Anna Gasparri, Luca Generoso, et al.
Pharmacological Research|February 13, 2022
Autoantibodies against the glial glutamate transporter GLT1/EAAT2 in Type 1 diabetes mellitus-Clues to novel immunological and non-immunological therapiesCarla Perego, Eliana S Di Cairano, Alessandra Galli, et al.
Frontiers in Oncology|January 11, 2021
Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal AdenocarcinomaMichele Reni, Valentina Andreasi, Anna Maria Gasparri, et al.
Skeletal Muscle|December 23, 2014
Deficient nitric oxide signalling impairs skeletal muscle growth and performance: involvement of mitochondrial dysregulationClara De Palma, Federica Morisi, Sarah Pambianco, et al.
Pharmacological Research|June 23, 2022
The anti-inflammatory and immunological properties of GLP-1 Receptor AgonistsGiulia Bendotti, Laura Montefusco, Maria Elena Lunati, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|October 20, 2010
Syntaxin 4 is required for acid sphingomyelinase activity and apoptotic functionCristiana Perrotta, Laura Bizzozero, Denise Cazzato, et al.
American Journal of Nephrology|December 5, 2012
Possible pathogenetic relationship between Fabry disease and renal cell carcinomaFabio Pagni, Federico Pieruzzi, Stefano Zannella, et al.
Mediators of Inflammation|June 24, 2015
Modulation of Acid Sphingomyelinase in Melanoma Reprogrammes the Tumour Immune MicroenvironmentEmma Assi, Davide Cervia, Laura Bizzozero, et al.
Frontiers in Immunology|July 26, 2021
Hematopoietic Stem Cells in Type 1 DiabetesIda Pastore, Emma Assi, Moufida Ben Nasr, et al.
Oncotarget|April 24, 2016
Essential role for acid sphingomyelinase-inhibited autophagy in melanoma response to cisplatinDavide Cervia, Emma Assi, Clara De Palma, et al.
Oncotarget|May 21, 2016
Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse modelsMimma Bianco, Anna Gasparri, Luca Generoso, et al.
Pharmacological Research|February 13, 2022
Autoantibodies against the glial glutamate transporter GLT1/EAAT2 in Type 1 diabetes mellitus-Clues to novel immunological and non-immunological therapiesCarla Perego, Eliana S Di Cairano, Alessandra Galli, et al.
Frontiers in Oncology|January 11, 2021
Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal AdenocarcinomaMichele Reni, Valentina Andreasi, Anna Maria Gasparri, et al.
Skeletal Muscle|December 23, 2014
Deficient nitric oxide signalling impairs skeletal muscle growth and performance: involvement of mitochondrial dysregulationClara De Palma, Federica Morisi, Sarah Pambianco, et al.
Pharmacological Research|June 23, 2022
The anti-inflammatory and immunological properties of GLP-1 Receptor AgonistsGiulia Bendotti, Laura Montefusco, Maria Elena Lunati, et al.
Pageof 4